Perrigo Says PSE Sales Up Again, Business From Leiner Helps Drive Growth
This article was originally published in The Tan Sheet
Executive Summary
Sales of Perrigo's pseudoephedrine-containing OTC products increased in its latest quarter for the first time since nonprescription PSE drugs were placed behind the counter in October 2006, the private-labeler said Nov. 1